Systemic CLIP-seq analysis and game theory approach to model microRNA mode of binding.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
21 06 2021
Historique:
accepted: 10 03 2021
revised: 19 02 2021
received: 08 09 2020
pubmed: 7 4 2021
medline: 15 7 2021
entrez: 6 4 2021
Statut: ppublish

Résumé

microRNAs (miRNAs) associate with Ago proteins to post-transcriptionally silence gene expression by targeting mRNAs. To characterize the modes of miRNA-binding, we developed a novel computational framework, called optiCLIP, which considers the reproducibility of the identified peaks among replicates based on the peak overlap. We identified 98 999 binding sites for mouse and human miRNAs, from eleven Ago2 CLIP-seq datasets. Clustering the binding preferences, we found heterogeneity of the mode of binding for different miRNAs. Finally, we set up a quantitative model, named miRgame, based on an adaptation of the game theory. We have developed a new algorithm to translate the miRgame into a score that corresponds to a miRNA degree of occupancy for each Ago2 peak. The degree of occupancy summarizes the number of miRNA-binding sites and miRNAs targeting each binding site, and binding energy of each miRNA::RNA heteroduplex in each peak. Ago peaks were stratified accordingly to the degree of occupancy. Target repression correlates with higher score of degree of occupancy and number of miRNA-binding sites within each Ago peak. We validated the biological performance of our new method on miR-155-5p. In conclusion, our data demonstrate that miRNA-binding sites within each Ago2 CLIP-seq peak synergistically interplay to enhance target repression.

Identifiants

pubmed: 33823551
pii: 6212755
doi: 10.1093/nar/gkab198
pmc: PMC8216473
doi:

Substances chimiques

3' Untranslated Regions 0
AGO2 protein, human 0
Ago2 protein, mouse 0
Argonaute Proteins 0
MicroRNAs 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e66

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

RNA. 2008 Aug;14(8):1480-91
pubmed: 18579870
PLoS Biol. 2004 Nov;2(11):e363
pubmed: 15502875
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Genes Dev. 2004 Mar 1;18(5):504-11
pubmed: 15014042
Cell. 2018 Mar 22;173(1):20-51
pubmed: 29570994
Algorithms Mol Biol. 2016 Apr 23;11:8
pubmed: 27110276
Cell. 2003 Dec 26;115(7):787-98
pubmed: 14697198
BMC Bioinformatics. 2008 Sep 02;9:361
pubmed: 18764936
Bioinformatics. 2016 Sep 15;32(18):2768-75
pubmed: 27207945
PLoS One. 2010 Jul 08;5(7):e11471
pubmed: 20628599
Nat Struct Mol Biol. 2010 Feb;17(2):173-9
pubmed: 20062054
RNA. 2004 Oct;10(10):1507-17
pubmed: 15383676
Nucleic Acids Res. 2007;35(7):2333-42
pubmed: 17389647
Cell. 2007 Dec 28;131(7):1273-86
pubmed: 18155131
BMC Bioinformatics. 2004 Aug 14;5:111
pubmed: 15310390
Nucleic Acids Res. 2014 Jan;42(Database issue):D68-73
pubmed: 24275495
Bioinformatics. 2011 Apr 1;27(7):1017-8
pubmed: 21330290
BMC Syst Biol. 2010 Feb 24;4:13
pubmed: 20181238
Mol Cell. 2007 Jul 6;27(1):91-105
pubmed: 17612493
Nucleic Acids Res. 2016 Sep 6;44(15):7120-31
pubmed: 27418678
Nature. 2009 Jul 23;460(7254):479-86
pubmed: 19536157
Nature. 2008 Nov 27;456(7221):464-9
pubmed: 18978773
Nat Struct Mol Biol. 2011 Nov 13;18(12):1428-31
pubmed: 22081015
Nat Commun. 2017 Oct 30;8(1):1189
pubmed: 29084942
Mol Cell. 2012 Dec 14;48(5):760-70
pubmed: 23142080
Nucleic Acids Res. 2018 Apr 20;46(7):3259-3269
pubmed: 29897601
Cell. 2013 Apr 25;153(3):654-65
pubmed: 23622248
Nat Methods. 2011 May 15;8(7):559-64
pubmed: 21572407
Genes Dev. 2013 Jul 15;27(14):1624-32
pubmed: 23824327
Source Code Biol Med. 2014 May 03;9:8
pubmed: 24955109
Mol Cell. 2016 Oct 20;64(2):320-333
pubmed: 27720646
Nucleic Acids Res. 2017 Jul 7;45(12):7212-7225
pubmed: 28482037
Nat Protoc. 2014 Feb;9(2):263-93
pubmed: 24407355
Bioinformatics. 2011 Dec 15;27(24):3333-40
pubmed: 21994224
Biophys J. 2007 Dec 1;93(11):L52-4
pubmed: 17872959
Cell. 2006 Jun 16;125(6):1111-24
pubmed: 16777601
Nucleic Acids Res. 2015 Jun 23;43(11):5263-74
pubmed: 25958398
Neuron. 2014 Jan 22;81(2):294-305
pubmed: 24389009
Dev Biol. 2004 Mar 15;267(2):529-35
pubmed: 15013811
Nucleic Acids Res. 2017 May 19;45(9):e71
pubmed: 28108660
Proc Natl Acad Sci U S A. 2020 Jul 28;117(30):17764-17774
pubmed: 32661162
Nucleic Acids Res. 2015 Aug 18;43(14):6730-8
pubmed: 26089388
Cell. 2013 Jan 17;152(1-2):82-96
pubmed: 23313552
Nature. 2008 Sep 4;455(7209):58-63
pubmed: 18668040
Cell. 2010 Apr 2;141(1):129-41
pubmed: 20371350
Mol Cell. 2010 May 28;38(4):576-89
pubmed: 20513432
Genes Dev. 2012 Jul 15;26(14):1626-42
pubmed: 22802532
Bioinformatics. 2011 Mar 15;27(6):863-4
pubmed: 21278185
Brief Bioinform. 2018 Nov 27;19(6):1290-1301
pubmed: 28605404
PLoS One. 2015 May 07;10(5):e0126325
pubmed: 25951061
Nucleic Acids Res. 2012 Oct;40(18):8818-34
pubmed: 22798498
Nat Struct Mol Biol. 2011 Feb;18(2):237-44
pubmed: 21258322
Elife. 2015 Aug 12;4:
pubmed: 26267216

Auteurs

Fabrizio Serra (F)

Inserm U1065, C3M, Team Control of Gene Expression (10), Nice, France.
Université Côte d'Azur, Inserm, C3M, Nice, France.

Silvia Bottini (S)

Inserm U1065, C3M, Team Control of Gene Expression (10), Nice, France.
Université Côte d'Azur, Inserm, C3M, Nice, France.

David Pratella (D)

Inserm U1065, C3M, Team Control of Gene Expression (10), Nice, France.
Université Côte d'Azur, Inserm, C3M, Nice, France.

Maria G Stathopoulou (MG)

Inserm U1065, C3M, Team Control of Gene Expression (10), Nice, France.
Université Côte d'Azur, Inserm, C3M, Nice, France.

Wanda Sebille (W)

Inserm U1065, C3M, Team Control of Gene Expression (10), Nice, France.
Université Côte d'Azur, Inserm, C3M, Nice, France.

Loubna El-Hami (L)

Inserm U1065, C3M, Team Control of Gene Expression (10), Nice, France.
Université Côte d'Azur, Inserm, C3M, Nice, France.

Emanuela Repetto (E)

Inserm U1065, C3M, Team Control of Gene Expression (10), Nice, France.
Université Côte d'Azur, Inserm, C3M, Nice, France.

Claire Mauduit (C)

Inserm U1065, C3M, Team Control of Gene Expression (10), Nice, France.
Université Côte d'Azur, Inserm, C3M, Nice, France.

Mohamed Benahmed (M)

Inserm U1065, C3M, Team Control of Gene Expression (10), Nice, France.
Université Côte d'Azur, Inserm, C3M, Nice, France.

Valerie Grandjean (V)

Inserm U1065, C3M, Team Control of Gene Expression (10), Nice, France.
Université Côte d'Azur, Inserm, C3M, Nice, France.

Michele Trabucchi (M)

Inserm U1065, C3M, Team Control of Gene Expression (10), Nice, France.
Université Côte d'Azur, Inserm, C3M, Nice, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH